{"organizations": [], "uuid": "3808f11fabfc0879590befe938ad10335da527d8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aradigm-submits-marketing-authoris/brief-aradigm-submits-marketing-authorisation-application-to-ema-for-eu-marketing-approval-of-linhaliq-idUSFWN1QR0FM", "country": "US", "domain_rank": 408, "title": "BRIEF-Aradigm Submits Marketing Authorisation Application To EMA For EU Marketing Approval Of Linhaliq", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T17:01:00.000+02:00", "replies_count": 0, "uuid": "3808f11fabfc0879590befe938ad10335da527d8"}, "author": "", "url": "https://www.reuters.com/article/brief-aradigm-submits-marketing-authoris/brief-aradigm-submits-marketing-authorisation-application-to-ema-for-eu-marketing-approval-of-linhaliq-idUSFWN1QR0FM", "ord_in_thread": 0, "title": "BRIEF-Aradigm Submits Marketing Authorisation Application To EMA For EU Marketing Approval Of Linhaliq", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "eu marketing approval of linhaliq", "sentiment": "negative"}, {"name": "eu", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "aradigm corp", "sentiment": "none"}, {"name": "aradigm", "sentiment": "none"}, {"name": "eu marketing approval of linhaliq reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - Aradigm Corp:\n* ARADIGM SUBMITS MARKETING AUTHORISATION APPLICATION (MAA) TO EMA FOR EU MARKETING APPROVAL OF LINHALIQ IN NON-CYSTIC FIBROSIS BRONCHIECTASIS Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-03-09T17:01:00.000+02:00", "crawled": "2018-03-09T17:17:21.047+02:00", "highlightTitle": ""}